18.04.2013 Views

role of th1 and th17 cd4+ t cell subsets in the pathogenesis of ...

role of th1 and th17 cd4+ t cell subsets in the pathogenesis of ...

role of th1 and th17 cd4+ t cell subsets in the pathogenesis of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>in</strong>flammation show <strong>in</strong>creased levels <strong>of</strong> CCR5, as well as <strong>of</strong> CCL3, CCL4 <strong>and</strong> CCL5<br />

(Balashov et al., 1999). In mice with EAE <strong>the</strong> same is true, but CCL3 <strong>and</strong> CCR5 deficient<br />

mice are not resistant to EAE immunization nor those treated with <strong>the</strong> antagonist met‐<br />

RANTES (Glab<strong>in</strong>ski et al., 1998;Tran et al., 2000a;Matsui et al., 2002).<br />

40<br />

1.5.2 CCR6 AND ITS LIGANDS<br />

CCR6, preferentially expressed by most B <strong>cell</strong>s, immature DCS <strong>and</strong> effector memory T<br />

<strong>cell</strong>s, was recently described to be expressed also <strong>in</strong> Th17 <strong>cell</strong>s <strong>and</strong> regulatory T <strong>cell</strong>s.<br />

CCL20 (MIP3‐α) but also, with lower aff<strong>in</strong>ity, <strong>the</strong> β‐defens<strong>in</strong> group <strong>of</strong> antimicrobial<br />

peptides b<strong>in</strong>d CCR6. Th17 <strong>cell</strong>s are also able to express CCL20, mak<strong>in</strong>g <strong>the</strong>m also<br />

potential recruiters <strong>of</strong> both Th17 <strong>and</strong> Tregs. Absence <strong>of</strong> CCR6 <strong>in</strong> Th17 <strong>cell</strong>s was found to<br />

slightly delay EAE onset, as <strong>in</strong> <strong>the</strong> case <strong>of</strong> CCR6 knock‐out mice (Yamazaki et al., 2008).<br />

CCR6 <strong>and</strong> CCL20 are up‐regulated <strong>in</strong> dra<strong>in</strong><strong>in</strong>g lymph nodes <strong>and</strong> sp<strong>in</strong>al cord dur<strong>in</strong>g EAE,<br />

<strong>and</strong> <strong>the</strong> disease can be attenuated with a neutraliz<strong>in</strong>g antibody or antagonist for CCR6<br />

(Liston et al., 2009). CCL20 is expressed ei<strong>the</strong>r constitutively or follow<strong>in</strong>g <strong>in</strong>duction <strong>in</strong> a<br />

variety <strong>of</strong> epi<strong>the</strong>lial <strong>cell</strong> types, <strong>in</strong>clud<strong>in</strong>g kerat<strong>in</strong>ocytes, pulmonary <strong>and</strong> <strong>in</strong>test<strong>in</strong>al<br />

epi<strong>the</strong>lial <strong>cell</strong>s <strong>and</strong> is highly <strong>in</strong>duced follow<strong>in</strong>g <strong>in</strong>flammatory stimuli. CCR6 seems to play<br />

a <strong>role</strong> <strong>in</strong> Th17 <strong>cell</strong>s migration to certa<strong>in</strong> <strong>in</strong>test<strong>in</strong>e microenvironments express<strong>in</strong>g CCL20<br />

where <strong>the</strong>se receptors can regulate <strong>the</strong> balance between effector <strong>and</strong> regulatory T <strong>cell</strong>s<br />

<strong>in</strong> <strong>the</strong> gut (Wang et al., 2009).<br />

1.5.3 CCR8 AND ITS LIGANDS<br />

CCR8 has been detected <strong>in</strong> Th2 <strong>cell</strong>s, regulatory T <strong>cell</strong>s, macrophages <strong>and</strong> microglia.<br />

CCR8 has only one lig<strong>and</strong>, CCL1 (I‐309). In MS lesions, phagocytic macrophages <strong>and</strong><br />

activated microglia were found positive for CCR8 <strong>and</strong> correlated with active<br />

demyel<strong>in</strong>ation (Trebst et al., 2003). CCR8 is also up‐regulated <strong>in</strong> EAE bra<strong>in</strong> <strong>and</strong> sp<strong>in</strong>al<br />

cord, as well as CCL1 <strong>in</strong> sp<strong>in</strong>al cord before EAE onset (Godiska et al., 1995). CCR8‐CCL1<br />

<strong>in</strong>teraction seems to be essential for <strong>the</strong> <strong>pathogenesis</strong> as CCR8 deficient mice develop<br />

later onset <strong>and</strong> milder EAE symptoms (Murphy et al., 2002)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!